mammography

Contrast-enhanced mammography in screening and symptomatic work

Contrast-enhanced mammography (CEM) is an advanced breast imaging technique that enhances traditional mammography with iodine-based contrast, offering both structural and functional insights. It significantly improves cancer detection, especially in women with dense breast tissue, where conventional mammography often falls short. CEM demonstrates high sensitivity and specificity, rivalling breast MRI in many diagnostic scenarios, including pre-operative […]

Dr Vasiliki Papalouka

Dr Vasiliki Papalouka

Barts Health NHS Trust, London

Read Article

Breast screening and health inequalities: one screening service’s experience of addressing health inequalities

Breast screening services have always had a responsibility to encourage breast screening attendance. It has become evident that health inequalities influence both screening uptake and cancer treatment pathways. Activity within services to increase breast screening attendance therefore needs to understand and address health inequalities. To access the full article as a pdf please sign up […]

Claire Bailey

Claire Bailey

St George's University Hospitals NHS Foundation Trust

Read Article

Factors that impact radiography advanced practitioners’ diagnostic efficacy

Breast cancer is the most commonly diagnosed cancer in the UK, with around 41,000 cases reported annually. Early detection is paramount, with nine out of 10 women surviving for at least five years when the cancer is caught in its early stages. The NHS Breast Screening Programme (NHSBSP) plays a critical role in improving survival […]

Noelle Clerkin

Belfast Health and Social Care Trust

Read Article

Temporal enhancement characteristics of contrast-enhanced mammography

Contrast-enhanced mammography (CEM) is a functional imaging technique that is becoming increasingly widespread in clinical practice. This advanced mammographic technique utilises dual-energy subtraction mammography in combination with an intravenous iodinated contrast agent to produce two sets of diagnostic mammographic images. The low energy images are equivalent to a standard full field digital mammogram, while the […]

Dr Sarah Savarides

University of Dundee

Read Article

Double reporting with arbitration in the symptomatic setting – is it worth it?

National breast screening and high risk screening mammograms in the UK are all double reported with arbitration. However, with regard to symptomatic mammogram reporting, the guidance does not stipulate that double reporting is required, which allows for variation in practice based on departmental protocols. Our service also double reported all non-breast screening mammograms, including symptomatic […]

Laura Sewell, Dr Kirsty McNeil, Dr Sarah Savarides

NHS Tayside, University of Dundee

Read Article

Testing the quality of image processing for human and AI readers

Generally, there are two main types of image processing applied to radiographic images: •pre-processing, which undertakes corrections for detector and x-ray field non-uniformities such as detector structural noise (‘for processing’). •post-processing, which aims to display the image optimally for the reader (‘for presentation’). This article discusses post-processing and focuses on mammography.

Alistair Mackenzie, John Loveland

Royal Surrey NHS Foundation Trust

Read Article

Experience of mammography AI in a UK screening centre

AI applications in the field of breast imaging have gained a great deal of interest. Despite the use of computer-aided detection in breast screening having been studied in the past, it was not until the last decade that developments in machine learning and processing power made it possible to apply AI to digital imaging and […]

Dr Gerald Lip, Sarah Philip, Michelle Cumming, Lana Fairburn

North East Scotland Breast Screening Centre

Read Article

Exploring whether FAST MRI could detect aggressive breast cancers earlier than mammography

Breast cancer is the most common cancer in the UK. Delays to breast cancer surgery as short as four weeks cost lives because treatments are effective and early detection improves survival. Early detection also makes it less likely that a mastectomy or chemotherapy are needed. The NHS population-risk screening programme offers women aged 50-70 a […]

Dr Lyn Jones, Dr Rebecca Geach

Bristol Breast Care Centre, Southmead Hospital

Read Article

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.